Abstract:The formalin test is a commonly used animal model of acute and tonic pain. However, the molecular targets of formaldehyde (FA, the main ingredient of the formalin solution) on primary nociceptor cells remain controversial. In this report, the effects of FA on electrophysiologically-identified primary nociceptor cells were evaluated in vitro and the roles of the vanilloid receptor TRPV1 in FA-produced activation of primary nociceptors were also examined at both cellular and behavioral levels. Of 92 acutely dissociated dorsal root ganglion (DRG) cells recorded by current patch-clamp technique, 34% were discharged by FA application with the mean onset latencies of the first action potential (AP) being (367.34+/-32.96) s. All the FA-sensitive cells were identified as nociceptor cells by their distinguishable features of AP including longer duration, existence of a hump (a shoulder or inflection) on the repolarizing phase, and longer after-hyperpolarization of APs. Co-application of capsazepine (CPZ), a competitive antagonist of TRPV1 receptors, could block FA-evoked firing with partial inhibition on the membrane depolarization of all cells tested. Of another 160 cells examined by confocal calcium imaging, 32% were shown to respond to FA with an intracellular Ca(2+) rise. Of 51 FA-sensitive cells, 67% were suppressed by CPZ, suggesting partial involvement of TRPV1 in mediation of the FA-evoked intracellular Ca(2+) rise. Under voltage-clamp mode, 41% of DRG cells were evoked to give rise to inward current with the remaining 59% being unchanged. In separate experiments on the other 56 FA-sensitive cells, concentration-dependent increase in the FA-evoked current amplitude was demonstrated. In comparison with controls, the FA-evoked inward current could be significantly suppressed by CPZ that was further enhanced by HC-030031, a TRPA1 selective antagonist. Finally, local effects of CPZ were confirmed in the formalin test and it was shown that the formalin-induced paw flinches were strongly suppressed by CPZ in phase 1 but with phase 2 being significantly suppressed only during 25-55 min. It is therefore concluded that FA can directly activate a subpopulation of primary nociceptor cells and the FA-induced AP discharges are likely to contribute mainly to phase 1, but not phase 2 of the formalin-induced nociception. The activation of primary nociceptor cells by FA is likely to be mediated, at least in part, through TRPV1 and/or TRPA1 receptors.

Activation of Serotonin 1A Receptors in Ventrolateral Orbital Cortex Depresses Persistent Nociception: a Presynaptic Inhibition Mechanism.

Correction: Divergent Modulation of Pain and Anxiety by GABAergic Neurons in the Ventrolateral Periaqueductal Gray and Dorsal Raphe.

Activation of 5-HT5A Receptor in the Ventrolateral Orbital Cortex Produces Antinociceptive Effects in Rat Models of Neuropathic and Inflammatory Pain

GABAergic Modulation is Involved in the Ventrolateral Orbital Cortex 5-HT 1A Receptor Activation-Induced Antinociception in the Rat.

The Pronociceptive Role of 5-HT6 Receptors in Ventrolateral Orbital Cortex in a Rat Formalin Test Model.

Attenuation of Formalin-Induced Inflammatory Nociception by Propentofylline: Modulation of Glia

Inhibitory effect of glutamate microinjected into the ventrolateral orbital cortex on the Fos expression in spinal dorsal horn neurons induced by formalin test in the rat

Involvement of Ventrolateral Orbital Cortex 5-HT 1–7 Receptors in 5-HT Induced Depression of Spared Nerve Injury Allodynia

The role of dopamine receptors in ventrolateral orbital cortex-evoked antinociception in a rat formalin test model.

D2-like but Not D1-like Dopamine Receptors Are Involved in the Ventrolateral Orbital Cortex-Induced Antinociception: a GABAergic Modulation Mechanism.

Involvement of 5-HT<sub>2A</sub>, 5-HT<sub>2B</sub> and 5-HT<sub>2C</sub> receptors in mediating the ventrolateral orbital cortex-induced antiallodynia in a rat model of neuropathic pain

The 5-HT6 Receptors in the Ventrolateral Orbital Cortex Attenuate Allodynia in a Rodent Model of Neuropathic Pain

The Role of Dopamine Receptors in Ventrolateral Orbital Cortex-Evoked Anti-Nociception in A Rat Model of Neuropathic Pain

Activation of mu-opioid receptors in thalamic nucleus submedius depresses bee venom-evoked spinal c-Fos expression and flinching behavior.

Activation of Α1 Adrenoceptors in Ventrolateral Orbital Cortex Attenuates Allodynia Induced by Spared Nerve Injury in Rats.

Inhibitory Effects of Electrically Evoked Activation of Ventrolateral Orbital Cortex on the Tail-Flick Reflex Are Mediated by Periaqueductal Gray in Rats

Synaptic Connections Between GABAergic Elements and Serotonergic Terminals or Projecting Neurons in the Ventrolateral Orbital Cortex.

Propagation of neuronal excitation in the rat central nucleus of amygdala revealed by the optical imaging

Mediating Roles of the Vanilloid Receptor TRPV1 in Activation of Rat Primary Afferent Nociceptive Neurons by Formaldehyde.

Activation of 5-HT6 Receptors in the Ventrolateral Orbital Cortex Produces Anti-Anxiodepressive Effects in a Rat Model of Neuropathic Pain

Effects of Intrathecal Monoamine Antagonists on the Nociceptive C-Fos Expression in A Lesioned Rat Spinal Cord